BETHANY FRANCIS: Open Payments
NPI 1437757895 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 33 payments from 12 companies in 2025. Trend: 2023 $879 · 2024 $1,017 · 2025 $928
Food & beverage: $833Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $362 |
| Astellas Pharma US Inc | 2 | $115 |
| Sumitomo Pharma America, Inc. | 4 | $96 |
| Boston Scientific Corporation | 2 | $73 |
| Telix Pharmaceuticals | 2 | $53 |
| IMMUNITYBIO, INC. | 2 | $49 |
| Edap Technomed Inc | 1 | $46 |
| Janssen Biotech, Inc. | 1 | $31 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $28 |
| Procept Biorobotics Corporation | 1 | $26 |
Products named: BOTOX, ILLUCCIX, ORGOVYX, ANKTIVA, FOCAL ONE, GEMTESA, Solyx SIS System, Axonics.
Industry payments across CA — which companies pay providers there.
